Cargando…

PD-L1 is preferentially expressed on CD44+ tumor-initiating cells in head and neck squamous cell carcinoma

Detalles Bibliográficos
Autores principales:	Lee, Yunqin, Sunwoo, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292581/ http://dx.doi.org/10.1186/2051-1426-2-S3-P270

Ejemplares similares

Cancer stem cells in head and neck squamous cell carcinoma
por: Karamboulas, Christina, et al.
Publicado: (2013)

MicroRNAs and cell proliferation in head and neck squamous cell carcinoma
por: Andreghetto, Flavia M, et al.
Publicado: (2013)

Characterization of CD44 variant expression in head and neck squamous cell carcinomas
por: Spiegelberg, D., et al.
Publicado: (2013)

Expression of CD44 in Head and Neck Squamous Cell Carcinoma—An In-Silico Study
por: Kavitha, Loganathan, et al.
Publicado: (2023)

Developing an immunotherapy strategy for the effective treatment of patients with squamous cell carcinoma of the head and neck
por: Moudgil, Tarsem, et al.
Publicado: (2013)

Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma
por: Farnebo, Lovisa, et al.
Publicado: (2015)

Evaluation of the immunogenicity of aldhhigh human head and neck squamous cell carcinoma cancer stem cells in vitro
por: Li, Qiao, et al.
Publicado: (2015)

Clinicopathological Significance of Expression of CD44 Variants in Head and Neck Squamous Cell Carcinoma
por: Kanke, Minoru, et al.
Publicado: (2000)

PD-1 is a marker of activation on tumor infiltrating NK cells in head and neck cancer
por: Concha-Benavente, Fernando, et al.
Publicado: (2015)

Variable density of CD8+ and CD25+ programmed cell death-1 (PD-1) ligand (PD-L1) CD4+ T cells within the tumor microenvironment causes differential responses to the PD-1/PD-L1 blockade
por: Wu, Si-Pei, et al.
Publicado: (2015)

An evaluation of autologous tumor-reactive TIL generation from head and neck squamous cell cancers
por: Mougdil, Tarsem, et al.
Publicado: (2015)

Characterizing the immunoprofile and endogenous immune response to squamous cell carcinomas of the head and neck to guide development of effective immunotherapy strategies
por: Moudgil, Tarsem, et al.
Publicado: (2014)

Shotgun proteomic analysis of human head and neck squamous cell carcinoma cell line SQ20B with diminished AHSG expression
por: Iyamu, Georgina, et al.
Publicado: (2014)

Targeting CD44v6 for fluorescence-guided surgery in head and neck squamous cell carcinoma
por: Odenthal, Julia, et al.
Publicado: (2018)

CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma
por: Murillo-Sauca, Oihana, et al.
Publicado: (2014)

OX40 and other immunoregulatory molecules are highly expressed on tumor infiltrating lymphocytes in oral, head and neck squamous cell carcinoma
por: Montler, Ryan, et al.
Publicado: (2014)

Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma
por: Rasmussen, Jacob H., et al.
Publicado: (2019)

CD44v6 specific CAR-NK cells for targeted immunotherapy of head and neck squamous cell carcinoma
por: Ciulean, Ioana Sonya, et al.
Publicado: (2023)

CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches
por: Spiegelberg, Diana, et al.
Publicado: (2017)

Semaphorin 4D produced by human head and neck squamous cell carcinoma induces myeloid derived suppressor cells expansion from peripheral blood monocytes
por: Younis, Rania H, et al.
Publicado: (2015)

Characterization of a cytoskeletal signaling pathway underpinning CD44-initiated, integrin-mediated adhesion of breast cancer cells to bone marrow endothelium
por: McFarlane, S, et al.
Publicado: (2008)

Expression of PD-L1 and CD4+ tumor-infiltrating lymphocytes predict survival in head and neck squamous cell carcinoma
por: Fu, Ze-Ming, et al.
Publicado: (2022)

Radiation therapy and vaccination against tumor-specific EGFRvIII effectively clears tumors in a murine model of head and neck squamous cell carcinoma
por: Uhde, Lauren, et al.
Publicado: (2015)

PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
por: Müller, Tim, et al.
Publicado: (2017)

Oxygen Deprivation Modulates EGFR and PD-L1 in Squamous Cell Carcinomas of the Head and Neck
por: Zahnreich, Sebastian, et al.
Publicado: (2021)

Performance of Different Diagnostic PD-L1 Clones in Head and Neck Squamous Cell Carcinoma
por: Ribbat-Idel, Julika, et al.
Publicado: (2021)

CD44-Targeted Magnetic Nanoparticles Kill Head And Neck Squamous Cell Carcinoma Stem Cells In An Alternating Magnetic Field
por: Su, Zhan, et al.
Publicado: (2019)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

Epitope optimization of a DNA vaccine targeting SSX-2 leads to PD-1 upregulation on antigen-specific CD8 T cells and PD-L1 upregulation on tumor cells
por: Rekoske, Brian, et al.
Publicado: (2013)

Peripheral tolerance induced by apoptotic cells and PD-1+ CD8 T cells
por: Kazama, Hirotaka, et al.
Publicado: (2012)

CD44 regulates bone erosion and osteoclastogenesis in arthritis
por: Schett, G, et al.
Publicado: (2003)

The emerging role of CD44 in regulating skeletal metastasis
por: Hill, A, et al.
Publicado: (2006)

HBD3 Induces PD-L1 Expression on Head and Neck Squamous Cell Carcinoma Cell Lines
por: Gomez Hernandez, Maria Paula, et al.
Publicado: (2019)

Differential Expression of PD-L1 during Cell Cycle Progression of Head and Neck Squamous Cell Carcinoma
por: Schulz, Daniela, et al.
Publicado: (2021)

Induced overexpression of CD44 associated with resistance to apoptosis on DNA damage response in human head and neck squamous cell carcinoma cells
por: Ohkoshi, Emika, et al.
Publicado: (2016)

PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma
por: Ock, Chan-Young, et al.
Publicado: (2016)

PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma
por: Shen, Bin, et al.
Publicado: (2019)

PD-L1 expression in the microenvironment and the response to checkpoint inhibitors in head and neck squamous cell carcinoma
por: Evrard, D., et al.
Publicado: (2020)

Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma
por: Puladi, Behrus, et al.
Publicado: (2021)

Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma
por: Girolami, Ilaria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q54b9s7ele7m4s2vio084ppo0i